Immutep is continuing the AIPAC-003 trial, which enrolled 71 metastatic hormone receptor positive (HR+), HER2-negative/low or ...

Media Release The pivotal TACTI-004 Phase III trial in first line non-small cell lung cancer (1L NSCLC) continues to build momentum and is recruiting patients at a growing number of activated clinical ...

Meet the winners of Bustle's 2025 Beauty Icon Awards for next-gen skin pros: 10 facialists who combine cutting-edge tech with ...

A sensorial delight, the new Maelys Get-Taut Body Firming & Hydrating Mousse-to-Oil feels like whipped cream and its many ...

Mercury reports on navigating market volatility, emphasizing scenario planning, identifying leading indicators, and finding ...